ARCHIVES

Cancer Funding To Defense Dept. Is Threat To National Cancer Program, Broder Says

This article is from The Cancer Letter archive.

Vol. 19 No. 10 | March 5, 1993

Download PDF Visit The Full Archive

Related Articles

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

November 26, 2010

OCC Proposes Plan To Educate Patients, Physicians On Value Of Clinical Trials

January 8, 1988

For ADT Reduced Use

November 5, 2010

Page 2: The Debate Over Brigham’s Containment Bag Study

November 21, 2014

HHS To Determine Feasibility Of CHOP Evaluation

July 24, 1981

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986